甲磺酸伊马替尼中致突变杂质研究
摘要
关键词
全文:
PDF参考
[1]TheInternationalCouncilforHarmonisationofTechnicalRe-quirementsforPharmaceuticalsforHumanUse(ICH).Assess-mentandcontrolofDNAreactive(Mutagenic)inPharmaceuticalstolimitpotentialcarcinogenicrisk.[EB/OL].[2020-05-15].https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf.
[2]TheInternationalCouncilforHarmonisationofTechnicalRequirementsforPharmaceuticalsforHumanUse(ICH).Val-idationofAnalyticalProcedures:Textandmethodology[EB/OL].[2020-05-15].https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf.
[3]CarcinogenicPotencyDatabase[EB/OL].[2020-05-15].https://files.toxplanet.com/cpdb/chempages/METHYL%20METHANESUL-FONATE.html.
[4]A.Segal,A.Sellakumar;Inducibilityofthymiclymphomasinfemalehsd:(icr)brmicefollowingsubcutaneousinjectionofethyl-andisopropylmethanesulfonate[J]CancerLett.1989,44(3):199-204.
DOI: http://dx.doi.org/10.18686/xdhg.v2i4.31290
Refbacks
- 当前没有refback。